Synribo and Stools - watery - a phase IV clinical study of FDA data

Summary:

Stools - watery is reported as a side effect among people who take Synribo (omacetaxine mepesuccinate), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Zofran, and have Chronic myeloid leukaemia.

The phase IV clinical study analyzes which people have Stools - watery when taking Synribo. It is created by eHealthMe based on reports of 799 people who have side effects when taking Synribo from the FDA, and is updated regularly.

What is Synribo?

Synribo has active ingredients of omacetaxine mepesuccinate. eHealthMe is studying from 799 Synribo users. Check the latest studies of Synribo.

What is Stools - watery?

Stools - watery is found to be associated with 4,673 drugs and 5,938 conditions by eHealthMe. Check the latest studies of Stools - watery.

On Jul, 20, 2026

799 people reported to have side effects when taking Synribo.
Among them, 73 people (9.14%) have Stools - watery.

Among these 73 people:

How long have people been on Synribo when they have Stools - watery? *

What is the gender of people who have Stools - watery when taking Synribo? *

female: 52.05 %
male: 47.95 %

What is the age of people who have Stools - watery when taking Synribo? *

What are other drugs people take besides Synribo? *

What are other side effects people have besides Stools - watery? *

Nausea (feeling of having an urge to vomit): 30 people, 41.10%
Nausea And Vomiting: 22 people, 30.14%
Pain: 15 people, 20.55%
Headache (pain in head): 15 people, 20.55%
Weakness: 14 people, 19.18%
Injection Site Erythema (redness at injection site): 14 people, 19.18%
Fatigue (feeling of tiredness): 12 people, 16.44%
Thrombocytopenia (decrease of platelets in blood): 12 people, 16.44%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 8 people, 10.96%
Dehydration (dryness resulting from the removal of water): 7 people, 9.59%

What are the existing conditions these people have? *

Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 67 people, 91.78%
High Blood Pressure: 7 people, 9.59%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 4.11%
Pain: 3 people, 4.11%
Diabetes: 3 people, 4.11%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 4.11%
High Blood Cholesterol: 3 people, 4.11%
Anaemia (lack of blood): 2 people, 2.74%
Heart Disease: 2 people, 2.74%
Stress And Anxiety: 2 people, 2.74%

* Approximation only. Some reports may have incomplete information.

Do you take Synribo and have Stools - watery?

- Check whether Stools - watery is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Synribo:

Synribo (799 reports)

Stools - watery treatments and more:

Stools - watery (756,290 reports)

Browse all side effects of Synribo:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Stools - watery:

Stools - watery (4,673 drugs)

Browse all the conditions that are associated with Stools - watery:

Stools - watery (5,938 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on omacetaxine mepesuccinate (the active ingredients of Synribo) and Synribo (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.